SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Caprius(CAPR), Breast MRI(former ANMR/MAMO) -- Ignore unavailable to you. Want to Upgrade?


To: Maxwell Fashola who wrote (2035)10/26/1997 1:50:00 PM
From: luis a. garcia  Read Replies (1) | Respond to of 2615
 
Maxwell I had thought the float commonfloat will be 7 million common shares. then GE bought preffered shares 2 or 3 mill.. when they bought back the high field technology agreement they had with ANMR they then invested in the new Company I think 2 mill preffered shares.
the price of the stock will be around 2.10 to 2.50 but probably higher because Faulkner grand opening will get press on the 28th of the month.
Your assesment is essentially correct. Take or average in your position and over time we may do allright.
ANMR will operate the Faulkner center in partnership with it and will
benefit from revenue there. Same thing will occur in other places as they sell the revenue sharing programs to other specialty breast clinics around the world. They have the opportunity to sell systems outright with maintenance and upgrades.. or sell revenue sharing partnerships with depriciation and revenue partaking with the clinics.
There are a lot of long term investors out there and I wish them and us well going forward.

You understand they are in a multisite study design to show the FDA they meet the minimum xray standards as they apply to xray machines then their idea is to also show the FDA they meet much higher standards than merely xrays... So at the very least they want legitimacy in the diagnostic world and in the reimbursement world of medicaid and medicare and private insurances.. and they want to set an MRI standard wich is higher than xrays.

luis



To: Maxwell Fashola who wrote (2035)10/27/1997 2:15:00 PM
From: Michael B Williams  Read Replies (2) | Respond to of 2615
 
I don't know but by math it looks like the dudes at mamo are getting a good deal on the backs of the ANMR stockholders. If one assumes that the ANMR .25 price holds and MAMO current price of .75 holds it sure seems that after the 1:10 reverse split where ANMR is now $2.50 that a holder of a share of MAMO at .75 gets a .4 share of ANMR that's worth $1. How come the holders of a company, (MAMO), that's on the verge of being bankrupt gets a 33% premimum for their part in the merger?

Anyone have a different take on this? I don't see where voting yes with my shares gets me anything. Why not let MAMO go bankrupt and pick it up for 10 or 20 cents on the dollar or could it be that there might really be that conflict of interest that the proxie package alludes to is there, with Jack and his friends being on both boards? Just some thoughts.

Michael